Abstract
The primary defect in Duchenne muscular dystrophy (DMD) is unknown but muscle growth failure and wasting of skeletal muscle must be the result of an imbalance between protein synthesis and degradation, that is, the rate of muscle protein synthesis is insufficient to replace degraded proteins and expand the protein mass. In patients with DMD, excretion of 3-methylhistidine is dramatically increased relative to creatinine and this is commonly accepted as evidence of increased muscle myofibrillar degradation1–3. As rapid wasting of muscle has not been observed to occur in the disease, increased protein degradation ought to be accompanied by increased protein synthesis and this has been observed or implied from measurements in animal models of the disease4–6. However, so far no direct measurements of muscle protein synthesis or degradation have been made in patients. We report here the first direct measurements in vivo of rates of skeletal muscle protein synthesis in patients suffering from DMD. The results, obtained using stable isotope tracers, clearly show that a marked reduction in muscle protein synthesis is the primary cause of the growth failure and that muscle protein degradation cannot be elevated.
Similar content being viewed by others
References
McKeran, R. O., Halliday, D. & Purkiss, P. J. Neurol. Neurosurg. Psychiat. 40, 979–981 (1977).
Ballard, F. J., Tomas, F. M. & Stern, L. M. Clin. Sci. 56, 347–352 (1979).
Warnes, D. M., Tomas, F. M. & Ballard, F. J. Muscle Nerve 4, 2–11 (1981).
Garber, A. J., Schwartz, R. J., Seidel, C. L., Silvers, A. & Entman, M. L. J. biol. Chem. 255, 8315–8324 (1980).
Li, J. B. Am. J. Physiol. 239, 401–406 (1981).
Hillgartner, F. B., Williams, A. S., Flanders, J. A., Morin, D. & Hansen, R. J. Biochem. J. 196, 591–601 (1980).
Matthews, D. E. et al. Am. J. Physiol. 238, E473–E481 (1980).
Edwards, R., Young, A. & Wiles, M. New Engl. J. Med. 302, 261–271 (1980).
Waterlow, J. C., Garlick, P. J. & Millward, D. J. Protein Turnover in Mammalian Tissues and in the Whole Body (Elsevier, Amsterdam, 1978).
Adibi, S. A. Metabolism 25, 1287–1302 (1976).
Halliday, D. & McKeran, R. O. Clin. Sci. molec. Med. 49, 581–590 (1975).
Simon, O., Munchmeyer, R., Bergner, H., Zebrowska, T. & Buraczewska, L. Br. J. Nutr. 40, 243–252 (1978).
Graystone, J. E. in Human Growth (ed. Cheek, D. B.) 182–197 (Lea & Febiger, Philadelphia, 1968).
Millward, D. J. Reprod. Nutr. Dév. 21, 265–277 (1981).
Young, V. R. & Munro, H. N. Fedn Proc. 37, 2291–2297 (1979).
Murray, C. E., Warnes, D. M., Ballard, F. J. & Tomas, F. M. Clin. Sci. 61, 737–741 (1981).
Millward, D. J. et al. Biochem. J. 190, 225–228 (1980).
Bates, P. C. & Millward, D. J. Proc. Nutr. Soc. 40, 89A (1981).
Millward, D. J., Bates, P. C., Broadbent, P. & Rennie, M. J. Proc. 3rd Congr. European Society on Parenteral and Enteral Nutrition (ed. Wesdorp, E. C.) (Churchill-Livingstone, Edinburgh, in the press).
Afting, E. G., Bernhardt, W., Janzen, R. W. C. & Röthig, H. J. Biochem. J. 220, 449–452 (1981).
Elia, M., Carter, A. & Smith, R. Br. J. Nutr. 42, 567–570 (1979).
Jackson, C. M. Am. J. Anat. 9, 119–124 (1909).
Forbes, B. M., Cooper, A. R. & Mitchell, H. H. J. biol. Chem. 203, 359–367 (1953).
Read, M. A. et al. Proc. 3rd Congr. European Society on Parenteral and Enteral Nutrition (ed. Wesdorp, R. C.) (Churchill-Livingstone, Edinburgh, in the press).
Millward, D. J. in Degradative Processes in Skeletal and Cardiac Muscle (ed. Wildenthal K.) 161–200 (Elsevier, Amsterdam, 1980).
Rennie, M. J., Edwards, R. H. T. & Millward, D. H. Muscle Nerve (in the press).
McGowan, E. P., Shafiq, S. A. & Stracher, A. Expl Neurol. 50, 649–652 (1976).
Stracher, A., McGowan, E. B. & Shafiq, S. A. Science 200, 500–501 (1978).
Libby, P., Ingwall, J. G. & Goldberg, A. L. Am J. Physiol. 237, E35–E39 (1979).
Matthews, D. E., Ben-Galim, E. & Bier, D. M. Analyt. Chem. 51, 80–88 (1979).
Halliday, D. & Read, W. W. C. Proc. Nutr. Soc. 40, 321–334 (1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rennie, M., Edwards, R., Millward, D. et al. Effects of Duchenne muscular dystrophy on muscle protein synthesis. Nature 296, 165–167 (1982). https://doi.org/10.1038/296165a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/296165a0
- Springer Nature Limited
This article is cited by
-
Sulfur amino acid supplementation displays therapeutic potential in a C. elegans model of Duchenne muscular dystrophy
Communications Biology (2022)
-
Poly A RNA status and expression of milli (m) and micro (μ) calpains in skeletal muscle of duchenne muscular dystrophy patients
Indian Journal of Clinical Biochemistry (2002)
-
Lung function in Duchenne muscular dystrophy
European Spine Journal (1995)
-
Proteases in normal and diseased human skeletal muscle: a preliminary histochemical survey
The Histochemical Journal (1985)